cell-mediated immunity , determined by reactivity to a battery of recall antigens , revealed that 56 % ( 5 ) of group i patients were able to maintain their skin test reactivity throughout the postoperative course compared with 94 % ( 17 ) in group ii .
C0020966
cell-mediated immunity
C0003320
antigens